Address book
Contacts
MARCO KRENGLI
Position
Professore Ordinario
Address
VIA GIUSTINIANI, 3 - PADOVA
Telephone
0498218864
Full Professor of Radiotherapy at the Department of Surgical, Oncological and Gastroenterological Sciences of the University of Padova. Until 2022, full Professor of Radiotherapy at the Department of Translational Medicine of the University of Eastern Piedmont. He is dean of the Medical School. He is director of the Radiation Oncology Division and director of the Department of Specialized Medicine and Oncology of the Azienda Ospedaliero-Universitaria "Maggiore della Carità" in Novara. He specialized in Oncology, Radiotherapy, and Radiology. In 1995-96, he was Research Fellow at Harvard University. The research interests concern EORTC studies (brain, head and neck tumors), prognostic factors in head and neck tumors, protontherapy in skull base tumors and retinoblastoma, methodology for integrating CT, MRI, and SPECT images in radiotherapy planning and intra-operative radiation therapy. He authored more than 200 articles in scientific journals (H-index = 37), more than 400 abstracts in conference proceedings and 18 chapters in scientific books. He is member of ESTRO (European Society for Therapeutic Radiology and Oncology), ASTRO (American Society for Therapeutic radiology and Oncology), EORTC (European Organization for Research and Treatment of Cancer), PTCOG (Proton Therapy COperative Group), ISIORT (International Society for Intra-Operative Radiation Therapy), AIRO (Associazione Italiana di radioterapia Oncologica), AIRB (Associazione Italiana di Radiobiology), FONCAM (Forza Operativa Nazionale su Carcinoma Mammario), SIB (Società Italiana del Basicranio).
Notices
Office hours
Wednesday from 14:00 to 16:00
at UOC Radioterapia, Istituto Oncologico Veneto IRCCS, via Giustiniani, 2
per appuntamenti: marco.krengli@unipd.it
Teachings
- DIAGNOSTIC IMAGING 2 AND ONCOLOGICAL RADIOTHERAPY, AA 2024 (MEP7080707)
- DIAGNOSTIC IMAGING 2 AND ONCOLOGICAL RADIOTHERAPY, AA 2024 (MEP7080707)
- DIAGNOSTIC IMAGING 2 AND ONCOLOGICAL RADIOTHERAPY, AA 2023 (MEP7080707)
- DIAGNOSTIC IMAGING 2 AND ONCOLOGICAL RADIOTHERAPY, AA 2023 (MEP7080707)
- PRECISION ONCOLOGY WITH INTEGRATED TREATMENTS, AA 2023 (MEQ3104567)
- PRECISION CANCER TREATMENT WITH PROTON THERAPY, AA 2023 (MEQ3104200)
Publications
Stacchiotti S, et al. Best practices for the management of local-regional recurrent chordoma. A position paper by the Chordoma Consensus Group. Ann Oncol, 28: 1230-42, 2017 doi: 10.1093/annonc/mdx054
Thariat J, et al. Using Proton Beam Therapy in the Elderly Population: A Snapshot of Current Perception and Practice. Int J Radiat Oncol Biol Phys, 98: 840-2, 2017 10.1016/j.ijrobp.2017.01.007
Salas S, et al. Prediction of local and metastatic recurrence in solitary fibrous tumor: construction of a risk calculator in a multicenter cohort from the French Sarcoma Group (FSG) database. Ann Oncol 28: 1979-87, 2017 doi:10.1093/annonc/mdx250
Krengli M, et al. Radiotherapy in the treatment of extracranial Hemangiopericytoma/Solitary Fibrous Tumor: study from the Rare Cancer Network. Radiother Oncol 144: 114-120, 2020
Terlizzi M, et al. Postoperative radiotherapy in patients with extracranial chondrosarcoma. A joint study of the French Sarcoma Group and Rare Cancer Network. Int J Radiat Oncol Biol Phys, 2020 doi: 10.1016/j.ijrobp.2020.03.041
Zeppegno P, et al. Psychotherapy with music intervention improves anxiety, depression and the redox status in breast cancer patients undergoing radiotherapy: a randomized controlled clinical trial. Cancers, 13: 1752, 2021
Pisani C, et al. Apoptotic and predictive factors by Bax, Caspases 3/9, Bcl-2, p53 and Ki-67 in prostate cancer after 12 Gy single-dose. Sci Rep, 10:7050, 2020. doi: 10.1038/s41598-020-64062-9
Krengli M, et al. 18-FDG PET/CT as predictive and prognostic factor in esophageal cancer treated with combined modality treatment. Ann Nucl Med, 36: 450-9, 2022 DOI 10.1007/s12149-022-01733-9
Research Area
Integrated imaging for radiotherapy (CT, MRI, PET, SPECT)
Combined chemo-radiotherapy for head and neck tumours
Proton and Carbon ion therapy for skull base and spine tumours
Intra-operative radiotherapy
Radiotherapy for Rare Tumours
Quality Assurance and Risk Management in Radiation Oncology